{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:50:42Z","timestamp":1789069842611,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["NARSAD Young Investigator Award"],"award-info":[{"award-number":["NARSAD Young Investigator Award"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 085667 Clear"],"award-info":[{"award-number":["R01 085667 Clear"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41380-018-0106-5","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T09:32:56Z","timestamp":1529400776000},"page":"906-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Treatment response prediction and individualized identification of first-episode drug-na\u00efve schizophrenia using brain functional connectivity"],"prefix":"10.1038","volume":"25","author":[{"given":"Bo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"106_CR1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575\u201386.","journal-title":"Lancet"},{"key":"106_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.schres.2014.12.022","volume":"173","author":"D Fraguas","year":"2016","unstructured":"Fraguas D, Diaz-Caneja CM, Pina-Camacho L, Janssen J, Arango C. Progressive brain changes in children and adolescents with early-onset psychosis: a meta-analysis of longitudinal MRI studies. Schizophr Res. 2016;173:132\u20139.","journal-title":"Schizophr Res"},{"key":"106_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"S Moylan","year":"2012","unstructured":"Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012;18:595\u2013606.","journal-title":"Mol Psychiatry"},{"key":"106_CR4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1399-5618.2007.00484.x","volume":"9","author":"M Berk","year":"2007","unstructured":"Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9:671\u20138.","journal-title":"Bipolar Disord"},{"key":"106_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12581","volume":"134","author":"IC Passos","year":"2016","unstructured":"Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134:91\u2013103.","journal-title":"Acta Psychiatr Scand"},{"key":"106_CR6","doi-asserted-by":"crossref","unstructured":"Cao B, Passos IC, Mwangi B, Amaral-Silva H, Tannous J, Wu M-J, et al. Hippocampal subfield volumes in mood disorders. Mol Psychiatry. 2017;22:1352\u20131358.","DOI":"10.1038\/mp.2016.262"},{"key":"106_CR7","doi-asserted-by":"crossref","unstructured":"Ho NF, Iglesias JE, Sum MY, Kuswanto CN, Sitoh YY, De Souza J, et al. Progression from selective to general involvement of hippocampal subfields in schizophrenia. Mol Psychiatry. 2017 Jan; 22(1): 142\u2013152","DOI":"10.1038\/mp.2016.4"},{"key":"106_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.116","volume":"2","author":"A Vita","year":"2012","unstructured":"Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2:e190.","journal-title":"Transl Psychiatry"},{"key":"106_CR9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4088\/JCP.15m10278","volume":"2012","author":"M Cloutier","year":"2016","unstructured":"Cloutier M, Sanon Aigbogun M, Guerin A, Nitulescu R, Ramanakumar AV, Kamat SA, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;2012:764\u201371.","journal-title":"J Clin Psychiatry"},{"key":"106_CR10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroimage.2013.08.053","volume":"84","author":"HG Schnack","year":"2014","unstructured":"Schnack HG, Nieuwenhuis M, van Haren NEM, Abramovic L, Scheewe TW, Brouwer RM, et al. Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage. 2014;84:299\u2013306.","journal-title":"Neuroimage"},{"key":"106_CR11","first-page":"1742","volume":"40","author":"J Kambeitz","year":"2016","unstructured":"Kambeitz J, Cabral C, Sacchet MD, Gotlib IH, Zahn R, Serpa MH, et al. Detecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studies. Biol Psychiatry. 2016;40:1742\u201351.","journal-title":"Biol Psychiatry"},{"key":"106_CR12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","volume":"37","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev. 2013;37:1680\u201391.","journal-title":"Neurosci Biobehav Rev"},{"key":"106_CR13","unstructured":"Baglivo V, Cao B, Mwangi B, Bellani M, Perlini C, Lasalvia A, et al. Hippocampal subfield volumes in patients with first-episode psychosis. Schizophrenia Bulletin. 2017;44:3, 6 April 552\u2013559."},{"key":"106_CR14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.schbul.a033413","volume":"25","author":"RA Emsley","year":"1999","unstructured":"Emsley RA. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Schizophr Bull. 1999;25:721\u20139.","journal-title":"Schizophr Bull"},{"key":"106_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-8-31","volume":"8","author":"E Johnsen","year":"2008","unstructured":"Johnsen E, J\u00f8rgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry. 2008;8:31","journal-title":"BMC Psychiatry"},{"key":"106_CR16","doi-asserted-by":"publisher","unstructured":"Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, et al. Risperidone versus other atypical antipsychotics for schizophrenia. In: Cochrane Database of Systematic Reviews. 2011 https:\/\/doi.org\/10.1002\/14651858.CD006626.pub2 .","DOI":"10.1002\/14651858.CD006626.pub2"},{"key":"106_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0170-2","volume":"16","author":"C Wang","year":"2017","unstructured":"Wang C, Shi W, Huang C, Zhu J, Huang W, Chen G. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-na\u00efve schizophrenia: a randomized comparative trial. Ann Gen Psychiatry. 2017;16:47 https:\/\/doi.org\/10.1186\/s12991-017-0170-2","journal-title":"Ann Gen Psychiatry"},{"key":"106_CR18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","volume":"163","author":"R Emsley","year":"2006","unstructured":"Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry. 2006;163:743\u20135.","journal-title":"Am J Psychiatry"},{"key":"106_CR19","doi-asserted-by":"publisher","unstructured":"Rattehalli RD, Zhao S, Li BG, Jayaram MB, Xia J, Sampson S Risperidone versus placebo for schizophrenia. Cochrane Database Syst. Rev. 2016; 2016. https:\/\/doi.org\/10.1002\/14651858.CD006918.pub3 .","DOI":"10.1002\/14651858.CD006918.pub3"},{"key":"106_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179\u201394.","journal-title":"Neuroimage"},{"key":"106_CR21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","volume":"30","author":"J Jovicich","year":"2006","unstructured":"Jovicich J, Czanner S, Greve D, Haley E, Van Der Kouwe A, Gollub R, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage. 2006;30:436\u201343.","journal-title":"Neuroimage"},{"key":"106_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355.","journal-title":"Neuron"},{"key":"106_CR23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380.","journal-title":"Neuroimage"},{"key":"106_CR24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.neuroimage.2009.05.089","volume":"47","author":"D Zhou","year":"2009","unstructured":"Zhou D, Thompson WK, Siegle G. MATLAB toolbox for functional connectivity. Neuroimage. 2009;47:1590\u2013607.","journal-title":"Neuroimage"},{"key":"106_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1098\/rstb.2005.1645","volume":"360","author":"R Salvador","year":"2005","unstructured":"Salvador R, Suckling J, Schwarzbauer C, Bullmore E. Undirected graphs of frequency-dependent functional connectivity in whole brain networks. Philos Trans R Soc B Biol Sci. 2005;360:937\u201346.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"106_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1191\/0962280203sm341ra","volume":"12","author":"T Nichols","year":"2003","unstructured":"Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12:419\u201346.","journal-title":"Stat Methods Med Res"},{"key":"106_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"106_CR28","doi-asserted-by":"publisher","unstructured":"Pedregosa F, Varoquaux G Scikit-learn: Machine learning in Python. 2011 https:\/\/doi.org\/10.1007\/s13398-014-0173-7.2 .","DOI":"10.1007\/s13398-014-0173-7.2"},{"key":"106_CR29","volume":"8","author":"B Cao","year":"2018","unstructured":"Cao B, Luo Q, Fu Y, Du L, Qiu T, Yang X, et al. Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder. Sci Rep. 2018;8:5434.","journal-title":"Sci Rep"},{"key":"106_CR30","doi-asserted-by":"crossref","unstructured":"Cortes C, Vapnik V. Support-vector networks. Machine Learning. 1995;20(3):273\u2013297.","DOI":"10.1007\/BF00994018"},{"key":"106_CR31","unstructured":"Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale Rating Criteria. 1999."},{"key":"106_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2013.00133","volume":"7","author":"MR Arbabshirani","year":"2013","unstructured":"Arbabshirani MR, Kiehl KA, Pearlson GD, Calhoun VD. Classification of schizophrenia patients based on resting-state functional network connectivity. Front Neurosci. 2013;7:1\u201316.","journal-title":"Front Neurosci"},{"key":"106_CR33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.62.11.1218","volume":"62","author":"C Davatzikos","year":"2005","unstructured":"Davatzikos C, Shen D, Gur RCRE, Wu X, Liu D, Fan Y, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry. 2005;62:1218\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"106_CR34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.biopsych.2009.07.019","volume":"66","author":"D Sun","year":"2009","unstructured":"Sun D, van Erp TGM, Thompson PM, Bearden CE, Daley M, Kushan L, et al. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry. 2009;66:1055\u201360.","journal-title":"Biol Psychiatry"},{"key":"106_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41537-017-0022-8","volume":"3","author":"M Gheiratmand","year":"2017","unstructured":"Gheiratmand M, Rish I, Cecchi GA, Brown MRG, Greiner R, Polosecki PI, et al. Learning stable and predictive network-based patterns of schizophrenia and its clinical symptoms. npj Schizophr. 2017;3:22.","journal-title":"npj Schizophr"},{"key":"106_CR36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/schbul\/sbs095","volume":"39","author":"S Borgwardt","year":"2013","unstructured":"Borgwardt S, Koutsouleris N, Aston J, Studerus E, Smieskova R, Riecher-R\u00f6ssler A, et al. Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition. Schizophr Bull. 2013;39:1105\u201314.","journal-title":"Schizophr Bull"},{"key":"106_CR37","doi-asserted-by":"crossref","unstructured":"Liu Y, Teverovskiy L, Carmichael O, Kikinis R, Shenton M, Carter CS, et al. Discriminative MR image feature analysis for automatic schizophrenia and Alzheimer\u2019s disease classification. In: MICCAI. Medical Image Computing and Computer-Assisted Intervention \u2013 MICCAI 2004, 393\u2013401.","DOI":"10.1007\/978-3-540-30135-6_48"},{"key":"106_CR38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S0033291711002005","volume":"42","author":"J Mourao-Miranda","year":"2012","unstructured":"Mourao-Miranda J, Reinders AATS, Rocha-Rego V, Lappin J, Rondina J, Morgan C, et al. Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study. Psychol Med. 2012;42:1037\u201347.","journal-title":"Psychol Med"},{"key":"106_CR39","doi-asserted-by":"crossref","unstructured":"Rathi Y, Malcolm J, Michailovich O, Goldstein J, Seidman L, McCarley RW, et al. Biomarkers for identifying first-episode schizophrenia patients using diffusion weighted imaging. Med image Comput Comput Interv Part 1 2010: 657\u201365.","DOI":"10.1007\/978-3-642-15705-9_80"},{"key":"106_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.inffus.2013.02.002","volume":"19","author":"D Schwarz","year":"2014","unstructured":"Schwarz D, Kasparek T. Brain morphometry of MR images for automated classification of first-episode schizophrenia. Inf Fusion. 2014;19:97\u2013102.","journal-title":"Inf Fusion"},{"key":"106_CR41","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1017\/S003329171300024X","volume":"43","author":"W Pettersson-Yeo","year":"2013","unstructured":"Pettersson-Yeo W, Benetti S, Marquand AF, Dell\u2019acqua F, Williams SCR, Allen P, et al. Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level. Psychol Med. 2013;43:2547\u201362.","journal-title":"Psychol Med"},{"key":"106_CR42","first-page":"1","volume":"2975","author":"A Ramyead","year":"2015","unstructured":"Ramyead A, Studerus E, Kometer M, Uttinger M, Gschwandtner U, Fuhr P, et al. Prediction of psychosis using neural oscillations and machine learning in neuroleptic-naive at-risk patients. World J Biol Psychiatry. 2015;2975:1\u201311.","journal-title":"World J Biol Psychiatry"},{"key":"106_CR43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2006.09.009","volume":"89","author":"SE Chua","year":"2007","unstructured":"Chua SE, Cheung C, Cheung V, Tsang JTK, Chen EYH, Wong JCH, et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res. 2007;89:12\u201321.","journal-title":"Schizophr Res"},{"key":"106_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01677063.2014.908875","volume":"28","author":"CY Pietersen","year":"2014","unstructured":"Pietersen CY, Mauney Sa, Kim SS, Passeri E, Lim MP, Rooney RJ, et al. Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia. J Neurogenet. 2014;28:1\u201316.","journal-title":"J Neurogenet"},{"key":"106_CR45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2016.10.024","volume":"182","author":"TM Mueller","year":"2017","unstructured":"Mueller TM, Yates SD, Haroutunian V, Meador-Woodruff JH. Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia. Schizophr Res. 2017;182:66\u201373.","journal-title":"Schizophr Res"},{"key":"106_CR46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2016.02.018","volume":"177","author":"J Steiner","year":"2016","unstructured":"Steiner J, Brisch R, Schiltz K, Dobrowolny H, Mawrin C, Krzyzanowska M, et al. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: a post-mortem study. Schizophr Res. 2016;177:10\u201317.","journal-title":"Schizophr Res"},{"key":"106_CR47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pnpbp.2013.09.012","volume":"48","author":"W Guo","year":"2014","unstructured":"Guo W, Xiao C, Liu G, Wooderson SC, Zhang Z, Zhang J, et al. Decreased resting-state interhemispheric coordination in first-episode, drug-naive paranoid schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:14\u201319.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"106_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.297","volume":"7","author":"B McKinney","year":"2017","unstructured":"McKinney B, Ding Y, Lewis DA, Sweet RA. DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia. Transl Psychiatry. 2017;7:e1032.","journal-title":"Transl Psychiatry"},{"key":"106_CR49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/appi.ajp.2008.08020183","volume":"166","author":"S Lui","year":"2009","unstructured":"Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, et al. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: An optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry. 2009;166:196\u2013205.","journal-title":"Am J Psychiatry"},{"key":"106_CR50","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/schbul\/sbt110","volume":"40","author":"B Straube","year":"2014","unstructured":"Straube B, Green A, Sass K, Kircher T. Superior temporal sulcus disconnectivity during processing of metaphoric gestures in Schizophrenia. Schizophr Bull. 2014;40:936\u201344.","journal-title":"Schizophr Bull"},{"key":"106_CR51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S0033291716002683","volume":"47","author":"C Shah","year":"2017","unstructured":"Shah C, Zhang W, Xiao Y, Yao L, Zhao Y, Gao X, et al. Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis. Psychol Med. 2017;47:401\u201313.","journal-title":"Psychol Med"},{"key":"106_CR52","first-page":"604","volume":"147","author":"PE Barta","year":"1990","unstructured":"Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyrus volume in schizophrenia. Am J Psychiatry. 1990;147:604\u201312.","journal-title":"Am J Psychiatry"},{"key":"106_CR53","doi-asserted-by":"crossref","unstructured":"Friston KJ. The disconnection hypothesis. Schizophrenia Research 1998;30:115\u201325.","DOI":"10.1016\/S0920-9964(97)00140-0"},{"key":"106_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","volume":"72","author":"DK Sarpal","year":"2015","unstructured":"Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, et al. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry. 2015;72:5\u201313.","journal-title":"JAMA Psychiatry"},{"key":"106_CR55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1176\/appi.ajp.2015.14121571","volume":"173","author":"DK Sarpal","year":"2016","unstructured":"Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, et al. Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment. Am J Psychiatry. 2016;173:69\u201377.","journal-title":"Am J Psychiatry"},{"key":"106_CR56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114:169\u201379.","journal-title":"Br Med Bull"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0106-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T15:31:55Z","timestamp":1720366315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0106-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"B.C., R.Y.C., D.C., M.X., L.W., and X.Y.Z. reported no biomedical financial interests or potential conflicts of interest. J.C.S. has received grants\/research support from Forrest, BMS, J&J, Merck, Stanley Medical Research Institute, NIH and has been a speaker for Pfizer and Abbott.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}